| Product Name | MF | CAS | Details |
|---|
| LSKL, Inhibitor of Thrombospondin TSP-1 acetate | Details |
| sodium lauroyl-α-hydroxyethyl sulfonate | Details |
| 1H-Pyrazole-5-carboxamide, 4-(5-chloro-2-furanyl)-1,3-bis(2,4-difluorophenyl)-4,5-dihydro-5-methyl-N-[(4-methyl-2-morpholinyl)methyl | C27H25ClF4N4O3 | 2171015-78-2 | Details |
| Adrenocorticotropic Hormone (ACTH) (4-10) TFA, 10 mM in DMSO | Details |
| (2-{[2-(2-fluorophenoxy)ethyl]sulfanyl}-1H-benzimidazol-1-yl)acetic acid | C17H15FN2O3S | 303134-93-2 | Details |
| 2-benzylsulfanyl-6-methoxy-4-methylquinazoline, 10 mM in DMSO | C17H16N2OS | 500272-00-4 | Details |
| H-Asp(OtBu)-OtBu HCl | C12H24ClNO4 | 1791-13-5 | Details |
| Cis-5-Norbornene-exo-2,3-dicarboxylic Anhydride | C9H8O3 | 2746-19-2 | Details |
| N-terminally acetylated Leu-enkephalin | Details |
| Compound STK672155, 10 mM in DMSO | C27H21ClN2O7S | 339284-01-4 | Details |
| 1H-Pyrrolo[2,1-c][1,2,4]benzothiadiazine, 2,3,3a,4-tetrahydro-, 5,5-dioxide, (3aR)-, 10 mM in DMSO | C10H12N2O2S | 175340-21-3 | Details |
| DDG-39, 10 mM in DMSO | C9H12FN3O3 | 119555-47-4 | Details |
| 8-(4-iodophenyl)-1,3,5,7-tetramethyl BODIPY | C19H19BF2IN2 | 250734-47-5 | Details |
| CS-B1628 | C15H19BrN2O4S | 1434643-33-0 | Details |
| T807, 10 mM in DMSO | C16H10FN3 | 1415379-56-4 | Details |
| MMRi62, 10 mM in DMSO | C21H15Cl2N3O | 352693-80-2 | Details |
| 2-((9R,10S,11R,15S)-12,14-dioxo-9,10-dih, 10 mM in DMSO | C24H23NO4 | 475100-30-2 | Details |
| 1-(2-fluorophenyl)-3-[5-(2-methoxyphenyl)-1,3,4-thiadiazol-2-yl]urea | C16H13FN4O2S | 426242-86-6 | Details |
| Datelliptium chloride hydrochloride | C23H28ClN3O | 157000-76-5 | Details |
| 3-Phenyl-N-[1-(phenylmethyl)-4-piperidinyl]-tricyclo[3.3.1.13,7]decane-1-carboxamide, 10 mM in DMSO | C29H36N2O | 1252187-41-9 | Details |
| 2-(2-bromophenyl)-5-chloro-4H-3,1-benzoxazin-4-one, 10 mM in DMSO | C14H7BrClNO2 | 1234707-32-4 | Details |
| Fmoc-Cys(Acm)-OH, 10 mM in DMSO | C21H22N2O5S | 86060-81-3 | Details |
| (R)-Naroparcil | 252647-51-1 | Details |
| 2-CHLOROMETHYL-1,1-DIOXO-1,2-DIHYDRO-1LAMBDA*6*-BENZO[D]ISOTHIAZOL-3-ONE, 10 mM in DMSO | C8H6ClNO3S | 13947-21-2 | Details |
| ((3S,5R)-5-((1H-1,2,4-Triazol-1-yl)methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)methyl 4-methylbenzenesulfonate | C21H21F2N3O4S | 149809-43-8 | Details |
| W140 HBr, 10 mM in DMSO | C16H27N2O4P | 1246817-25-3 | Details |
| Thalidomide-O-amido-PEG3-C2-NH2 TFA | C25H31F3N4O11 | 1957236-21-3 | Details |
| cis-1-(3-Chloroallyl)-3,5,7-triaza-1-azoniaadamantane chloride | C9H16Cl2N4 | 51229-78-8 | Details |
| BDCRB | C12H11BrCl2N2O4 | 142356-43-2 | Details |
| COH-SR4, 10 mM in DMSO | C13H8Cl4N2O | 73439-19-7 | Details |
| N-(1-benzyl-4-piperidyl)adamantane-1-carboxamide, 10 mM in DMSO | C23H32N2O | 314030-54-1 | Details |
| 4-(9H-fluoren-9-ylmethoxycarbonylamino)-piperidine-1,4-dicarboxylic acid mono-tert-butyl ester, 10 mM in DMSO | C26H30N2O6 | 183673-66-7 | Details |
| Z-Asp(OBzl)-OH, 10 mM in DMSO | C19H19NO6 | 3479-47-8 | Details |
| (6Z)-7-Phenyl-7-(3-Pyridinyl)-6-Heptenoic Acid | C18H19NO2 | 89667-39-0 | Details |
| 3,7-dimethylocta-2,6-dienyl 5,9,13-trimethyltetradeca-4,8,12-enoate, 10 mM in DMSO | C27H44O2 | 16898-88-7 | Details |
| LSKL, Inhibitor of Thrombospondin TSP-1 acetate, 10 mM in DMSO | Details |
| N-[2-nitro-4-(trifluoromethyl)phenyl]piperazine, 10 mM in DMSO | C11H12F3N3O2 | 58315-38-1 | Details |
| T863, 10 mM in DMSO | C22H26N4O3 | 701232-20-4 | Details |
| Ethyl 1-(4-methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate | C27H28N4O5 | 503614-91-3 | Details |
| SOD1-Derlin-1 inhibitor 56-59, 10 mM in DMSO | C22H18N4OS | 2170170-27-9 | Details |
| Nav1.8-IN-1, 10 mM in DMSO | C20H15ClF3N3O2 | 1026822-49-0 | Details |
| Anisole-piperazine-methanone-benzothiazole-p-methylpiperidine, 10 mM in DMSO | C25H30N4O2S | 906258-69-3 | Details |
| 1-[(5-methylisoxazol-3-yl)methyl]piperazine, 10 mM in DMSO | C9H15N3O | 173850-51-6 | Details |
| 2-chloro-5-(16,18-dioxo-17-azapentacyclo[6.6.5.0~2,7~.0~9,14~.0~15,19~]nonadeca-2,4,6,9,11,13-hexaen-17-yl)benzoic acid, 10 mM in DM | C25H16ClNO4 | 327033-56-7 | Details |
| EM-651, 10 mM in DMSO | C29 H31 N O4 | 182167-58-4 | Details |
| 4-Pyridinecarboxaldehyde, 2-(2-pyridinyl)hydrazone, [C(E)]- | C11H10N4 | 2241017-37-6 | Details |
| 2,3-dihydro-1H-indene-5-sulfonamide, 10 mM in DMSO | C9H11NO2S | 35203-93-1 | Details |
| IHMT-PI3Kδ-372 S-isomer, 10 mM in DMSO | C26H23F2N7O2 | 2429889-61-0 | Details |
| Adrenocorticotropic Hormone (ACTH) (4-10) TFA | Details |
| Protease-Activated Receptor-4 diTFA | Details |
| Xanthine oxidoreductase-IN-5 | C17H17N5O2 | 1026652-90-3 | Details |
| Rel-5-(4-Chloro-2-fluorophenyl)-2,3-dimethyl-7-[(2R,4S)-tetrahydro-2-(1-methyl-1H-pyrazol-4-yl)-2H-pyran-4-yl]pyrido[3,4-b]pyrazine | C24H23ClFN5O | 2738485-99-7 | Details |
| 4-(4-Amino-3-fluorophenoxy)-N-methylpicolinamide | C13H12FN3O2 | 757251-39-1 | Details |
| 1-(4-AMinophenyl)-5,6-dihydro-3-(4-Morpholinyl)-2(1h)-pyridinone | C15H19N3O2 | 1267610-26-3 | Details |
| 4-benzyloxycarbonylamino-piperidine-1,4-dicarboxylic acid mono-tert-butyl ester, 10 mM in DMSO | C19H26N2O6 | 288154-16-5 | Details |
| SOD1-Derlin-1 inhibitor-1 | C19H12Br2N4OS | 840461-03-2 | Details |
| Thyrotropin-Releasing Hormone (TRH), Free Acid, 10 mM in DMSO | C16H21N5O5 | 24769-58-2 | Details |
| T6167923, 10 mM in DMSO | C17H20BrN3O3S2 | 2437475-16-4 | Details |
| 1H-Indole, 3,3''-(2-thienylmethylene)bis[2-methyl- | C23H20N2S | 138801-72-6 | Details |
| 2,5-Morpholinedione, 4-methyl-6-(1-methylethyl)-3-(phenylmethyl)- | C15H19NO3 | 2180287-51-6 | Details |
| (1R,5S,6r)-N-(2-methyl-1-((3-methylpyridin-2-yl)oxy)propan-2-yl)-3-azabicyclo[3.1.0]hexane-6-carboxamide L(+)-Tartaric acid | C16H23N3O2.C4H6O6 | 2919211-45-1 | Details |
| Protease-Activated Receptor-4 diTFA, 10 mM in DMSO | Details |
| (2S,3S)-3-Hydroxy-2-methyl-3-phenylpropanoic acid | C10H12O3 | 76549-02-5 | Details |
| 3-Morpholino-1-(4-(2-oxopiperidin-1-yl)phenyl)-5,6-dihydropyridin-2(1H)-one | C20H25N3O3 | 545445-44-1 | Details |
| N-[3,5-bis(trifluoroMethyl)phenyl]-N''-[(9R)-6''-Methoxycinchonan-9-yl]- Thiourea, 10 mM in DMSO | C29H28F6N4OS | 852913-25-8 | Details |
| Thalidomide-O-amido-C4-NH2 TFA, 10 mM in DMSO | C21H23F3N4O8 | 1799711-25-3 | Details |
| 1-benzyl-2-ethyl-4,5,6,7-tetrahydro-1H-indol-4-one, 10 mM in DMSO | C17H19NO | 218934-50-0 | Details |
| Phos-tag Acrylamide AAL-107 | C33H38N8O3 | 871839-54-2 | Details |
| CY5-SE triethylamine salt | C43H58N4O10S2 | 1497420-70-8 | Details |
| 4-(2-chloro-4-methoxy-5-methylphenyl)-N-[(1A)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]-5-methyl-N-(2-propyn-1-yl)-2-thiazolam | C27H28ClFN2OS | 2649012-21-3 | Details |
| 6-[(3S,8S,9S,10R,13S,14S,17S)-3-hydroxy-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]- | C26H31N3O2 | 1314134-92-3 | Details |
| 3-(2,6-dichlorobenzyl)-1-hexadecyl-2-methyl-1H-imidazol-3-ium iodide | Details |
| 3-(2,6-dichlorobenzyl)-1-hexadecyl-2-methyl-1H-imidazol-3-ium iodide, 10 mM in DMSO | Details |
| 2,3-BIS(N-BUTYLTHIO)-1,4-NAPHTHALENEDION | C18H22O2S2 | 671189-54-1 | Details |
| N4-benzyl-N2-methylquinazoline-2,4-diamine hydrochloride, 10 mM in DMSO | C16H17ClN4 | 1135272-09-1 | Details |
| Benzyl-piperazine-CO-benzothiazole-4-methylpiperidine, 10 mM in DMSO | C25H30N4OS | 906258-48-8 | Details |
| 2-(2-fluoro-6-methoxyphenyl)pyrimidine-4-carboxylic acid | C12H9FN2O3 | 1502645-66-0 | Details |
| (1S,2R)-Alicapistat, 10 mM in DMSO | C25H27N3O4 | 2221010-57-5 | Details |
| ZY-19489, 10 mM in DMSO | C24H32FN9 | 1821293-40-6 | Details |
| Methyl retinoate | C21H30O2 | 339-16-2 | Details |
| MOG peptide (35-55) , mouse, rat acetate | Details |
| (2R,3S,11bS)-9,10-dimethoxy-3-(2-methylpropyl)-1H,2H,3H,4H,6H,7H,11bH-pyrido[2,1-a]isoquinolin-2-ol | C19H29NO3 | 924854-62-6 | Details |
| Bz-RS-ISer(3-Ph)-Ome, 10 mM in DMSO | C17H17NO4 | 32981-85-4 | Details |
| EOB-DTPA | C23H33N3O11 | 158599-72-5 | Details |
| Fmoc-His-OH | C21H19N3O4 | 116611-64-4 | Details |
| Benzo[b]thiophene-7-propanoic acid, α-methoxy-4-[2-(5-methyl-2-phenyl-4-oxazolyl)ethoxy]-, (αR)-, 10 mM in DMSO | C24H23NO5S | 849150-59-0 | Details |
| (4S,5R)-3-tert-butoxycarbony-2-(4-anisy)-4-phenyl-5-oxazolidinecarboxylic acid, 10 mM in DMSO | C22H25NO6 | 196404-55-4 | Details |
| Thrombin Receptor Activator for Peptide | Details |
| 1-(4-chloro-3-(trifluoromethyl)phenyl)-3-(7-(1-methyl-1H-pyrazol-4-yl)-2,3,4,9-tetrahydro-1H-carbazol-3-yl)urea, 10 mM in DMSO | C24H21ClF3N5O | 2379727-88-3 | Details |
| Phenol, 2-methoxy-5-[(1Z)-2-(3,4,5-trimethoxyphenyl)ethenyl]-, 1,1''-(hydrogen phosphate) | C36H39O12P | 735261-22-0 | Details |
| 6''-hydroxydihydrocinchonidine | C19H24N2O2 | 5962-19-6 | Details |
| Fmoc-L-glutamic acid 5-tert-butyl ester | C24H27NO6 | 71989-18-9 | Details |
| (S)-3-AMino-2-Methylpropanoic acid-HCl, 10 mM in DMSO | C4H10ClNO2 | 925704-45-6 | Details |
| 6-Phenyldihydropyrimidine-2,4(1h,3h)-dione, 10 mM in DMSO | C10H10N2O2 | 6300-95-4 | Details |
| 2,4-Dioxaspiro(5.5)undec-8-ene, 3-(2-furanyl)-, 10 mM in DMSO | C13H16O3 | 80499-32-7 | Details |
| (2S)-4-biphenyl-4-yl-N-hydroxy-2-methyl-2-(methylsulfonyl)butanamide, 10 mM in DMSO | C18H21NO4S | 1354546-42-1 | Details |
| 1H-Benzimidazole-6-carboxamide, N-[3-(aminocarbonyl)-4,5,6,7-tetrahydrobenzo[b]thien-2-yl]- | C17H16N4O2S | 941185-83-7 | Details |
| A2B receptor antagonist 2 hydrochloride | C12H15N5.ClH | 724-70-9 | Details |
| N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-5-(N-ethylcyclopropanecarboxamido)-4-methyl-4′-morpholino-[1,1′-biphenyl]-3-c | C32H38N4O4 | 2238820-26-1 | Details |
| N′-(2-Chloroethyl)-N-(4-methylcyclohexyl)-N-nitrosourea | C10H18ClN3O2 | 75219-93-1 | Details |
| Product Total： Product Page： | ||||
| 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 | ||||